Hyperbaric Oxygen Therapy (HBOT) is a medical procedure that involves the administration of pure oxygen at high pressure within a specialized chamber. This treatment has been proven to be effective in managing various medical conditions, including necrotizing soft tissue infections, commonly referred to as flesh-eating disease.

What are Necrotizing Soft Tissue Infections?

NSTIs are a rare but potentially life-threatening bacterial infection that affects the soft tissues of the body. The infection can spread rapidly, causing tissue death and systemic illness. Symptoms of NSTIs may include fever, severe pain, swelling, and redness of the affected area. Immediate medical attention is necessary to prevent severe complications such as organ failure or death.

NSTIs are relatively rare, with an incidence rate of 0.4 to 0.8 cases per 100,000 people per year. However, the mortality rate of NSTIs can be high, with a reported mortality rate of up to 34%.

The standard treatment for NSTIs involves aggressive surgical debridement of the infected tissue and administration of antibiotics to control the infection. However, even with surgery and antibiotics, the prognosis for NSTIs can be poor, with significant morbidity and mortality rates.

Treating Flesh-Eating Disease with HBOT

HBOT has been found to be an effective adjunctive treatment for NSTIs. The therapy involves administering pure oxygen at a pressure greater than atmospheric pressure, which increases the amount of oxygen delivered to the body’s tissues, including the damaged tissue caused by NSTIs.

HBOT can help in the treatment of NSTIs in several ways. Firstly, the increased oxygenation of the tissues can help to promote the body’s immune response, which can aid in the control of the infection. Secondly, HBOT can help to reduce tissue hypoxia, which can improve the effectiveness of antibiotics in treating the infection. Thirdly, HBOT can help to reduce the production of bacterial toxins, which can contribute to tissue death and systemic illness.

Several studies have been conducted on the use of HBOT in the treatment of NSTIs, with promising results. A study published in the Journal of Surgical Research in 2016 found that the addition of HBOT to standard treatment significantly reduced the need for amputation and improved survival rates in patients with NSTIs. Another study published in the Annals of Plastic Surgery in 2018 reported similar results, with HBOT significantly reducing the number of surgical debridements and improving wound healing in patients with NSTIs.

Conclusion

In conclusion, NSTIs are a severe and potentially life-threatening bacterial infection that requires prompt and effective treatment. HBOT has been found to be an effective adjunctive treatment for NSTIs, with several studies demonstrating its ability to improve clinical outcomes and reduce morbidity and mortality rates. As with any medical treatment, HBOT should be administered under the supervision of a qualified healthcare professional.

Frequently Asked Questions on Hyperbaric Oxygen Therapy Treatments for Necrotizing Soft Tissue Infections

What is the role of Hyperbaric Oxygen Therapy (HBOT) in treating Necrotizing Soft Tissue Infections (NSTIs)?

HBOT is utilized as a crucial adjunct therapy alongside aggressive surgical debridement and broad-spectrum antibiotics for severe infections like necrotizing fasciitis, Fournier’s gangrene, and clostridial myonecrosis (gas gangrene). It helps halt the progression of tissue death and supports rapid infection control.

How does increased oxygen help combat NSTI pathogens like Clostridium perfringens?

Many bacteria responsible for the rapid destruction of tissue in NSTIs, especially Clostridium perfringens (which causes gas gangrene), are anaerobic. HBOT delivers oxygen at high pressure, creating a hyperoxic environment that is directly toxic to these anaerobic pathogens, inhibiting their growth and potent toxin production.

Does HBOT replace the need for surgery or debridement in necrotizing fasciitis?

Absolutely not. HBOT is always an adjunct to standard surgical and medical care. Immediate and extensive surgical debridement (removal of dead and infected tissue) remains the most critical intervention for NSTIs. HBOT helps protect compromised tissue bordering the surgical site and improves overall patient outcomes.

Can HBOT reduce the systemic toxicity associated with these life-threatening infections?

Yes. In conditions like gas gangrene, the hyperbaric environment helps inhibit the production and spread of lethal alpha toxins produced by Clostridium perfringens. By rapidly reducing the toxin load, HBOT can decrease systemic shock, reduce the risk of organ failure, and lower overall mortality rates associated with severe NSTIs.

How does HBOT support wound healing in tissues affected by NSTIs?

HBOT significantly increases plasma oxygen saturation, allowing oxygen to diffuse further into damaged, poorly perfused tissues. This improved tissue oxygenation supports angiogenesis (new blood vessel formation) and dramatically enhances the ability of the patient’s immune system, specifically white blood cells, to fight persistent infection in the wound bed.

How soon after diagnosis of a Necrotizing Soft Tissue Infection should HBOT begin?

HBOT should be initiated as an emergency intervention as soon as possible after diagnosis and initial surgical stabilization, ideally within hours. Early hyperbaric oxygen treatment is strongly correlated with better outcomes, reduced need for major amputations, and improved survival rates in these critical, life-threatening infections.

Is HBOT safe for patients critically ill with NSTIs who might require intensive care (ICU)?

When administered in a certified facility using multi-place chambers under the direct supervision of qualified medical staff, HBOT is safe even for critically ill and ventilated patients. Multi-place chambers allow continuous monitoring, ventilator support, and ongoing critical care to be maintained during the treatment session itself.

What is a typical course of HBOT treatment for severe Necrotizing Soft Tissue Infection cases?

The initial course is often aggressive to control the infection rapidly, potentially involving two or three treatments within the first 24 hours to halt anaerobic toxin production. The subsequent number of sessions varies greatly but may range from 10 to 30 total treatments depending on the patient’s clinical response, the extent of the tissue damage, and requirements for later reconstructive wound management.

Where can I find hyperbaric oxygen therapy centers specializing in treating complicated wound infections like Necrotizing Soft Tissue Infections?

If you are seeking professional, high-quality hyperbaric treatment in Western Canada, we encourage you to contact International Hyperbaric Health Centers Inc. (IHHC). We are conveniently located in Richmond, BC, serving the Greater Vancouver area and beyond. Our facility is equipped with three ASME/PVHO-certified hard-shelled multi-place chambers, ensuring optimal safety and capacity for complex cases. We are committed to providing affordable treatments and certified technicians, and we offer free consultations to discuss your specific needs.
International Hyperbaric Health Centers Inc. (IHHC).

How much does hyperbaric oxygen therapy cost for the management of Necrotizing Soft Tissue Infections?

Treatment costs depend on the required pressure, duration, and total number of sessions recommended by our consulting physician. Please refer to our current
hyperbaric oxygen therapy treatment rates on the home page for detailed pricing.